Intracellular Regulation of Cross-Presentation during Dendritic Cell Maturation

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Wagner, Claudia S ^a,b   Grotzke, Jeff ^a   Cresswell, Peter ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IMMATICS BIOTECHNOLOGIES GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR NECROSIS FACTOR ALPHA;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CROSS PRESENTATION; CYTOSOL; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOSTIMULATION; LYSOSOME; MACROPHAGE; MOUSE; NONHUMAN; PH; PHAGOCYTOSIS; PHAGOSOME; UPREGULATION;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; CD40 LIGAND; CELL DIFFERENTIATION; CPG ISLANDS; CROSS-PRIMING; DENDRITIC CELLS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOPOLYSACCHARIDES; LYSOSOMES; MICE; MICE, INBRED C57BL; OLIGODEOXYRIBONUCLEOTIDES; OVALBUMIN; PHAGOCYTOSIS; PHAGOSOMES; PRIMARY CELL CULTURE; PROTEIN TRANSPORT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84884822019     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076801     Document Type: Article

References (48)

1. Amigorena S, Savina A, (2010) Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol 22: 109-117. doi:10.1016/j.coi.2010.01.022. PubMed: 20171863.
2. Segura E, Villadangos JA, (2011) A modular and combinatorial view of the antigen cross-presentation pathway in dendritic cells. Traffic 12: 1677-1685. doi:10.1111/j.1600-0854.2011.01254.x. PubMed: 21777358.
3. Mellman I, Steinman RM, (2001) Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258. doi:10.1016/S0092-8674(01)00449-4. PubMed: 11509172.
4. Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S, (2002) Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 20: 621-667. doi:10.1146/annurev.immunol.20.100301.064828. PubMed: 11861614.
5. Wilson NS, Villadangos JA, (2005) Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv Immunol 86: 241-305. doi:10.1016/S0065-2776(04)86007-3. PubMed: 15705424.
6. Gil-Torregrosa BC, Lennon-Duménil AM, Kessler B, Guermonprez P, Ploegh HL, et al. (2004) Control of cross-presentation during dendritic cell maturation. Eur J Immunol 34: 398-407. doi:10.1002/eji.200324508. PubMed: 14768044.
7. West MA, Wallin RP, Matthews SP, Svensson HG, Zaru R, et al. (2004) Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling. Science 305: 1153-1157. doi:10.1126/science.1099153. PubMed: 15326355.
8. den Haan JM, Bevan MJ, (2002) Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med 196: 817-827. doi:10.1084/jem.20020295. PubMed: 12235214.
9. Regnault A, Lankar D, Lacabanne V, Rodriguez A, Théry C, et al. (1999) Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 189: 371-380. doi:10.1084/jem.189.2.371. PubMed: 9892619.
10. Delamarre L, Holcombe H, Mellman I, (2003) Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation. J Exp Med 198: 111-122. doi:10.1084/jem.20021542. PubMed: 12835477.
11. Datta SK, Redecke V, Prilliman KR, Takabayashi K, Corr M, et al. (2003) A subset of Toll-like receptor ligands induces cross-presentation by bone marrow-derived dendritic cells. J Immunol 170: 4102-4110. PubMed: 12682240.
12. Weck MM, Grünebach F, Werth D, Sinzger C, Bringmann A, et al. (2007) TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109: 3890-3894. doi:10.1182/blood-2006-04-015719. PubMed: 17218388.
13. Henri S, Siret C, Machy P, Kissenpfennig A, Malissen B, et al. (2007) Mature DC from skin and skin-draining LN retain the ability to acquire and efficiently present targeted antigen. Eur J Immunol 37: 1184-1193. doi:10.1002/eji.200636793. PubMed: 17407099.
14. Machy P, Serre K, Leserman L, (2000) Class I-restricted presentation of exogenous antigen acquired by Fcgamma receptor-mediated endocytosis is regulated in dendritic cells. Eur J Immunol 30: 848-857. doi:10.1002/1521-4141(200003)30:3. PubMed: 10741401.
15. Platt CD, Ma JK, Chalouni C, Ebersold M, Bou-Reslan H, et al. (2010) Mature dendritic cells use endocytic receptors to capture and present antigens. Proc Natl Acad Sci U S A 107: 4287-4292. doi:10.1073/pnas.0910609107. PubMed: 20142498.
16. Drutman SB, Trombetta ES, (2010) Dendritic cells continue to capture and present antigens after maturation in vivo. J Immunol 185: 2140-2146. doi:10.4049/jimmunol.1000642. PubMed: 20644175.
17. Wilson NS, Behrens GM, Lundie RJ, Smith CM, Waithman J, et al. (2006) Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol 7: 165-172. doi:10.1038/ni1300. PubMed: 16415871.
18. Wagner CS, Cresswell P, (2012) TLR and nucleotide-binding oligomerization domain-like receptor signals differentially regulate exogenous antigen presentation. J Immunol 188: 686-693. doi:10.4049/jimmunol.1102214. PubMed: 22156493.
19. Trombetta ES, Ebersold M, Garrett W, Pypaert M, Mellman I, (2003) Activation of lysosomal function during dendritic cell maturation. Science 299: 1400-1403. doi:10.1126/science.1080106. PubMed: 12610307.
20. Blander JM, Medzhitov R, (2004) Regulation of phagosome maturation by signals from toll-like receptors. Science 304: 1014-1018. doi:10.1126/science.1096158. PubMed: 15143282.
21. Blander JM, Medzhitov R, (2006) Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440: 808-812. doi:10.1038/nature04596. PubMed: 16489357.
22. Laroux FS, Romero X, Wetzler L, Engel P, Terhorst C, (2005) Cutting edge: MyD88 controls phagocyte NADPH oxidase function and killing of gram-negative bacteria. J Immunol 175: 5596-5600. PubMed: 16237045.
23. Vulcano M, Dusi S, Lissandrini D, Badolato R, Mazzi P, et al. (2004) Toll receptor-mediated regulation of NADPH oxidase in human dendritic cells. J Immunol 173: 5749-5756. PubMed: 15494527.
24. Delamarre L, Pack M, Chang H, Mellman I, Trombetta ES, (2005) Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 307: 1630-1634. doi:10.1126/science.1108003. PubMed: 15761154.
25. Savina A, Jancic C, Hugues S, Guermonprez P, Vargas P, et al. (2006) NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells. Cell 126: 205-218. doi:10.1016/j.cell.2006.05.035. PubMed: 16839887.
26. Jancic C, Savina A, Wasmeier C, Tolmachova T, El-Benna J, et al. (2007) Rab27a regulates phagosomal pH and NADPH oxidase recruitment to dendritic cell phagosomes. Nat Cell Biol 9: 367-378. doi:10.1038/ncb1552. PubMed: 17351642.
27. Savina A, Peres A, Cebrian I, Carmo N, Moita C, et al. (2009) The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. Immunity 30: 544-555. doi:10.1016/j.immuni.2009.01.013. PubMed: 19328020.
28. Mueller SN, Jones CM, Smith CM, Heath WR, Carbone FR, (2002) Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J Exp Med 195: 651-656. doi:10.1084/jem.20012023. PubMed: 11877488.
29. Belz GT, Behrens GM, Smith CM, Miller JF, Jones C, et al. (2002) The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196: 1099-1104. doi:10.1084/jem.20020861. PubMed: 12391021.
30. Salvucci LA, Bonneau RH, Tevethia SS, (1995) Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes. J Virol 69: 1122-1131. PubMed: 7529328.
31. Savina A, Vargas P, Guermonprez P, Lennon AM, Amigorena S, (2010) Measuring pH, ROS production, maturation, and degradation in dendritic cell phagosomes using cytofluorometry-based assays. Methods Mol Biol 595: 383-402. doi:10.1007/978-1-60761-421-0_25. PubMed: 19941126.
32. Singh R, Cresswell P, (2010) Defective cross-presentation of viral antigens in GILT-free mice. Science 328: 1394-1398. doi:10.1126/science.1189176. PubMed: 20538950.
33. Maric M, Arunachalam B, Phan UT, Dong C, Garrett WS, et al. (2001) Defective antigen processing in GILT-free mice. Science 294: 1361-1365. doi:10.1126/science.1065500. PubMed: 11701933.
34. Haque MA, Li P, Jackson SK, Zarour HM, Hawes JW, et al. (2002) Absence of gamma-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J Exp Med 195: 1267-1277. doi:10.1084/jem.20011853. PubMed: 12021307.
35. Phan UT, Arunachalam B, Cresswell P, (2000) Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J Biol Chem 275: 25907-25914. doi:10.1074/jbc.M003459200. PubMed: 10852914.
36. Lackman RL, Jamieson AM, Griffith JM, Geuze H, Cresswell P, (2007) Innate immune recognition triggers secretion of lysosomal enzymes by macrophages. Traffic 8: 1179-1189. doi:10.1111/j.1600-0854.2007.00600.x. PubMed: 17555533.
37. Lin ML, Zhan Y, Proietto AI, Prato S, Wu L, et al. (2008) Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset. Proc Natl Acad Sci U S A 105: 3029-3034. doi:10.1073/pnas.0712394105. PubMed: 18272486.
38. Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C, (2008) Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 9: 558-566. doi:10.1038/ni.1601. PubMed: 18376402.
39. Blander JM, Medzhitov R, (2006) On regulation of phagosome maturation and antigen presentation. Nat Immunol 7: 1029-1035. doi:10.1038/ni1006-1029. PubMed: 16985500.
40. Russell DG, Yates RM, (2007) Toll-like receptors and phagosome maturation. Nat Immunol 8: 217; author reply:-218. doi:10.1038/ni0307-217a. PubMed: 17304226.
41. Yates RM, Russell DG, (2005) Phagosome maturation proceeds independently of stimulation of toll-like receptors 2 and 4. Immunity 23: 409-417. doi:10.1016/j.immuni.2005.09.007. PubMed: 16226506.
42. Lennon-Duménil AM, Bakker AH, Maehr R, Fiebiger E, Overkleeft HS, et al. (2002) Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J Exp Med 196: 529-540. doi:10.1084/jem.20020327. PubMed: 12186844.
43. Yates RM, Russell DG, (2008) Real-time spectrofluorometric assays for the lumenal environment of the maturing phagosome. Methods Mol Biol 445: 311-325. doi:10.1007/978-1-59745-157-4_20. PubMed: 18425459.
44. Yates RM, Hermetter A, Russell DG, (2005) The kinetics of phagosome maturation as a function of phagosome/lysosome fusion and acquisition of hydrolytic activity. Traffic 6: 413-420. doi:10.1111/j.1600-0854.2005.00284.x. PubMed: 15813751.
45. Arunachalam B, Phan UT, Geuze HJ, Cresswell P, (2000) Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc Natl Acad Sci U S A 97: 745-750. doi:10.1073/pnas.97.2.745. PubMed: 10639150.
46. Belizaire R, Unanue ER, (2009) Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A 106: 17463-17468. doi:10.1073/pnas.0908583106. PubMed: 19805168.
47. Di Pucchio T, Chatterjee B, Smed-Sörensen A, Clayton S, Palazzo A, et al. (2008) Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat Immunol 9: 551-557. doi:10.1038/ni.1602. PubMed: 18376401.
48. Delamarre L, Mellman I, (2011) Harnessing dendritic cells for immunotherapy. Semin Immunol 23: 2-11. doi:10.1016/j.smim.2011.02.001. PubMed: 21377379.